Aditxt, Inc. Files 8-K with Financials and Exhibits
Ticker: ADTX · Form: 8-K · Filed: Mar 31, 2025 · CIK: 1726711
Sentiment: neutral
Topics: financial-statements, exhibits, regulation-fd
TL;DR
Aditxt filed an 8-K on 3/31 for events on 3/28, including financials.
AI Summary
Aditxt, Inc. filed an 8-K on March 31, 2025, reporting events as of March 28, 2025. The filing indicates a Regulation FD Disclosure and includes Financial Statements and Exhibits. The company, formerly known as Aditx Therapeutics, Inc., is incorporated in Delaware and operates in the Pharmaceutical Preparations sector.
Why It Matters
This 8-K filing provides updated financial information and exhibits for Aditxt, Inc., which is crucial for investors to assess the company's current financial health and strategic direction.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting financial statements and exhibits, not indicating any immediate material adverse events.
Key Players & Entities
- Aditxt, Inc. (company) — Registrant
- Aditx Therapeutics, Inc. (company) — Former company name
- March 28, 2025 (date) — Date of earliest event reported
- March 31, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- 2834 (sic_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What is the primary purpose of this 8-K filing by Aditxt, Inc.?
The primary purpose of this 8-K filing is to provide a Regulation FD Disclosure and to report Financial Statements and Exhibits as of March 28, 2025.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on March 28, 2025.
What was Aditxt, Inc.'s former company name?
Aditxt, Inc.'s former company names were Aditx Therapeutics, Inc. and ADiTx Therapeutics, Inc.
In which state is Aditxt, Inc. incorporated?
Aditxt, Inc. is incorporated in Delaware.
What is the Standard Industrial Classification code listed for Aditxt, Inc.?
The Standard Industrial Classification code listed for Aditxt, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 31, 2025 regarding Aditxt, Inc. (ADTX).